We demonstrated that the AD-attributed effects were accompanied by activation of apoptosis-dependent caspases (caspase-3, caspase-8, and caspase-9) and JNK kinases, as evidenced using relevant inhibitors. The gene discussed is CASP3; the disease is Alzheimer disease.